A growing number of physicians are starting to shift their thinking about multiple myeloma’s prognosis. For years, patients ...

CAR-T therapy for myeloma faces challenges in early-line use due to accessibility, eligibility criteria and long wait times, ...

In fact, all people with multiple myeloma will have a relapse or become resistant to treatment at some point. 1 Recent data from newly diagnosed ... which happens during or shortly after their first ...

CARTITUDE-4 compared Carvykti to a pair of three-drug multiple myeloma regimens – pomalidomide ... antibody Darzalex (daratumumab) into first-line treatment and growing its two bispecific ...

The study highlights the importance of including patient self-assessment—and not just clinician assessment—when planning ...

The new approval is a boost for Sanofi because the VRd regimen has become the preferred first-line treatment option for transplant-ineligible multiple myeloma patients in recent years, giving ...

It is important to maintain good nutrition during treatment for multiple myeloma. The food you eat can help you manage treatment side effects. For example, certain side effects of Revlimid ...

First-line treatments may include autologous hematopoietic ... While the study was able to identify socioeconomic disparities in myeloma treatment options, Esteghamat and her colleagues could ...